CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer

PALO ALTO, Calif., Feb. 27 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) today advised its stockholders to take no action at this time in response to Astellas Pharma Inc.'s announcement that its indirect subsidiary, Sturgeon Acquisition, Inc., has commenced an unsolicited tende...

Comprehensive Health Reform: A Must Pass This Year

WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement regarding President Obama's address to a joint session of Congress last night: "PhRMA applauds President Obama for ...

DNA 11, Creators of DNA Art, Introduces a More Affordable Line of Custom Portraits for this Year's Gift Giving Season

The new DNA Mini Portrait™ is this years' most unique must-have gift New York, NY(PRWEB) November 26, 2008 --DNA 11, the innovators and creators of custom portraits made from the customers' DNA, launch DNA Mini Portraits™, a more affordable line of DNA Art t...

Zounds Offers the Gift of Hearing This Holiday Season With a Range of New Products

PHOENIX, Nov. 26 /PRNewswire/ -- Zounds Hearing, a unique manufacturing and retail company focused on providing hearing devices with state-of-the-art fidelity, price point and professional service, announces the introduction of assistive listening devices (ALDs) in an effort to aid all who are har...

Early-Bird Registration Ends this Week for 10th Annual Quality Excellence Conference: How Process Improvement Leaders Produce Profits in Recessions

CHAPEL HILL, N.C., Aug. 28 /PRNewswire/ -- Be inspired by historic Philadelphia, Pa. and revel in the ambiance of a five-star hotel at a discounted group room rate while you discover best practices and network with executives from Abbott, Boeing, BP, DuPont, FedEx, Hewlett-Packard, Johnson & J...

POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year

Production of cellulosic ethanol in Scotland, S.D. to start in Q4 '08. Sioux Falls, S.D. (Vocus) August 13, 2008 -- At the American Coalition for Ethanol conference, http://www.poet.com [POET] announced that construction will be completed on a $4 million pilot-scale c...

FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas

SAN MARINO, Calif., July 9 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of all soft tissue sarcomas. This latest approval is the third clinical indicatio...

Awareness of Genzyme's Renvela(R) (Sevelamer Carbonate) is High, Although Uptake of this New Phosphate Binding Agent has Been Slower than Nephrologists and Renal Dietitians Initially Expected

EXTON, Pa., May 23 /PRNewswire/ -- BioTrends Research Group, Inc. released Wave 1 of its LaunchTrends(TM): Renvela report, the second in a multi-phase syndicated market research project tracking the launch of Renvela from baseline awareness through the first six months of product availability....

Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year

FREDERICK, Md., Feb. 27 /PRNewswire/ -- Vaccinogen, Inc. announced that its new vaccine to block colon cancer from recurring will be commercially available in Europe starting June 2008. "This makes OncoVAX(R) the world's first commercially viable vaccine for colon cancer," said Dr. Michael G...

Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Society's 29th Annual Meeting

WEST BRIDGEWATER, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO ) ("PBI") today announced that data highlighting the advantages of pressure cycling technology (PCT) in studies to (1) better understand the events surrounding stroke, (2) detect biomarkers of...

Who is this Adam Bock Person, Anyway?

The world of venture financing abounds in colorful characters. Madison, Wisconsin If youve been reading this series to learn more about tech start-ups and finance, be warned that todays lessons are purely anecdotal and experiential. Quaerendo invenietis . There may be lessons here, but remembe...

GenTel claims $900,000 in federal grants this year for biochip research

Stained bacteria cells adhering to spots on a plastic slide. Source: National Institute of Standards and Technology . MADISON, Wis. Five small business innovation research (SBIR) grants totaling more than $900,000 have been awarded to GenTel BioSurfaces, Inc. this year by the National Institu...

Life science VC and biotech confabs to fly solo this fall

MADISONAfter partnering up for two years, the Wisconsin Life Sciences and Venture Conference and the Wisconsin Biotech & Medical Device Conference have decided to go their separate ways. Due to different target audiences and themes, these autumn conferences are now being planned separately. ...

New Information Security Certificate offered at MATC this fall

MADISON The Madison Area Technical College is offering a new certificate in online security through the schools Computer Information Systems Department this fall. The CIS-Information Security Certificate was sprung from a $210,000 grant from the National Science Foundation given in November of l...

Wisconsin publicly traded biomedical companies report gains this quarter

Wisconsin's biotechnology industry has continued its growth, with three publicly traded biotech and health-care companies showing an improvement in revenues and net income over the last quarter. Due to new products and investments, the companies have been able to secure a foothold on the industry. ...

Twenty ways you can tell this campaign has finally pushed you over the edge

It's been a long campaign season, and you've been poked and prodded by television ads, pollsters and even the occasional national press corps member. John Kerry drank a beer at your neighborhood bar and George W. Bush read a book at your local kindergarten. Dick Cheney was spotted more in Wiscons...

Kanavas thinks personal ID theft bill will pass this year

State Senator Ted Kanavas remains optimistic that his bill requiring notification of electronic data breaches will pass the legislature yet this year. Senate Bill 164, co-authored by Kanavas, R-Brookfield, and Representative Jeff Fitzgerald, R-Horicon, would require companies that keep personal...

ITEC coming to Milwaukee this year

ITEC , the nation's largest series of business-to-business IT events, is coming to Milwaukee again on June 22 and 23 at the Midwest Airlines Center. The tradeshow and exposition will feature both global and Wisconsin-area technology companies. The conference will feature Microsoft , Intel , ...

Sonic Foundry expects break-even this year

Madison, Wis. Sonic Foundry said its revenues for the quarter ended December 31 were up 18 percent year-to-year. The firm took in $1.9 million for the quarter, compared to $1.6 million a year ago. A company statement said revenue is expected to pick up later this year and projected cashflow b...

National broadband policy: Let's get it right this time

Some people are talking about having a National Broadband Strategy, and that is a good issue to discuss. However, the one cautionary comment I would have is: Let's get it right this time. Several articles have popped up that discuss the need, but do not reflect some of the keys to making it ri...

Growth spurts

...num Nanocrystal Growth Trajectories." Co-authoring this paper with Zheng, Alivisatos and Dahmen were Rache...sis nanocrystals with desired physical properties. this will require a much better understanding of colloi...les in solution. The Berkeley researchers deployed this technique on NCEM's JEOL 3010 In-Situ microscope. ...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

... Forward-looking Statements The information in this press release may contain various forward-looking ...time in the Company's filings with the SEC. this discussion is not exhaustive, but is designed to h...f the forward-looking statements after the date of this press release. All forward-looking statements attr...

Schering-Plough Shareholders Approve Merger With Merck

...he strengths and diversity we have created. As we move closer to realizing this merger, we will continue to focus on driving our business and advancing our...financial considerations). DISCLOSURE NOTICE: The information in this press release and other written reports and oral statements made from time ...

Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading

...e. According to several authorities in the field, this is incorrect, as both studies actually demonstrate.... McJunkin explained that "Clinical data show that this procedure relieves pain and improves patients' qua...highly clinically significant reductions in pain. this demonstrates that vertebroplasty is an effective p...

REPEL-CV(TM) Adhesion Barrier Receives Endorsement of Kids With Heart

... "We want to inform parents of children with congenital heart defects about this new surgical device that reduces the risks associated with adhesions during...n its proprietary bioresorbable polymer technologies. Statements in this press release that are not statements of historical fact, constitute "forwa...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

...products we have developed for growing segments of this field in both the US and international markets. We...ficant reductions to our operating expenses so far this year and are continuing to evaluate additional are... compared to $279,571 for the same period in 2008. this decrease is primarily due to lower royalty income ...

Novavax Reports Second Quarter 2009 Financial Results

...ng top-line immunogenicity and safety results from this study by the fourth quarter of this year. Improved the company's balance sheet b...tch of the company's VLP vaccine candidate against this virus within 11 weeks of receiving the genetic seq...

Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product

...e defects of the knee. The clinical trial, which is expected to start later this year, will utilize the Company's Cartilage Repair Device, which consists of...Jude Medical, Inc. Cautionary Note for Forward-Looking Statements. this press release contains forward-looking statements that reflect the Company'...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

...the third quarter of 2009. Based on the results of this analysis, we will evaluate what measures, if any, ... "We are extremely pleased that the results of this important trial have been published by a medical journal of this caliber," commented Mr. McEnany. "Catalyst is plea...

NeurogesX Reports Second Quarter 2009 Results

... the recent data requests from the FDA. We believe this revised timeline allows us to stay on track, assum...oximately $48.8 million due from Astellas. Despite this significant transaction, we will continue to prior...he potential to commence significant activities in this program late...

AOBO Announces New Product Launch

... selectively antagonizes peripheral H1-receptors. this unique mechanism enables Jingwei to quickly allevi...nter products in China. Statements made in this press release are forward-looking and are made pur...ose described in the forward looking statements in this press release. The Company undertakes no obligati...

Viral Genetics Creates Subsidiary to Develop Cancer Therapy

...holly owned subsidiary called MetaCytoLytics, Inc. this company was created to advance a technology develo...icer of the new company. He will focus on bringing this concept forward into clinic trials and expanding t...he technology platform. "The potential for this technology platform is quite exciting," said Dr. T...

American Oriental Bioengineering Reports Second Quarter 2009 Financial Results

...uarter of 2009. We also made significant progress this quarter optimizing our distribution business, so t...nter products in China. Statements made in this press release are forward-looking and are made pur...ose described in the forward looking statements in this press release. The Company undertakes no obligati...

ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA

... SA kit that facilitates the testing process for this biomarker. this ELISA is unique; it is a departure from other meth...in using the same ELISA is preferable to eliminate this source of bias in the ratio. The interest i...

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

...DGAR on the SEC website at www.sec.gov . this communication shall not constitute an offer to sel...sorafenib) tablets, a small molecule drug. this news release also contains "forward-looking statem...oking statements that speak only as of the date of this release. Onyx undertakes no obligation to update ...

AutoImmune Inc. Reports 2009 Second Quarter Financial Results

...further announcements from BioMS and Lilly regarding their future plans for this approach to treating SPMS." AutoImmune is a biopharmaceutical comp...d cell-mediated inflammatory diseases and conditions. Statements in this release that are not strictly historical are forward-looking statements for...

ThermoGenesis Announces Expanded Collaboration With Celling Technologies

...edic products, based in Texas. As part of this expanded collaboration, ThermoGenesis and Celling ...orking with them with the launch of Res-Q and with this broader collaboration agreement. We expect that p...is designed for bone marrow stem cell processing. this product was launched in July 2009. The Cryo...

Synthetech Reports First Quarter Fiscal 2010 Results

...versities and drug discovery firms. Forward-Looking Statements this press release contains "forward looking" statements within the meaning of t...nce on these forward-looking statements, which speak only as of the date of this press release. Risks and uncertainties that could cause actual results to ...

Microbix Sales Grow 22% For Nine Months

...on by the second quarter of 2010. The advantage of this plan is to remove the need for the first round of ...l time. Semen Sexing Technology (SST) In this third quarter, Microbix focused on strengthening i... to the current commercial sexing technology. With this new technological advantage, the Company is enteri...

GenVec Reports Second Quarter 2009 Financial Results

...es to fight malaria through MVI and USAID funding. this contract is valued at approximately $2 million ove... to support the Company's malaria vaccine program. this grant, valued at approximately $600,000 over two y...from a single institutional investor. Proceeds of this transaction, net of offering costs, totaled $5.5 m...